Innova Captab Limited

NSE INNOVACAP.NS

Innova Captab Limited Market Capitalization on January 31, 2025: USD 637.28 M

Innova Captab Limited Market Capitalization is USD 637.28 M on January 31, 2025, a 78.93% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Innova Captab Limited 52-week high Market Capitalization is USD 910.15 M on January 07, 2025, which is 42.82% above the current Market Capitalization.
  • Innova Captab Limited 52-week low Market Capitalization is USD 308.40 M on March 28, 2024, which is -51.61% below the current Market Capitalization.
  • Innova Captab Limited average Market Capitalization for the last 52 weeks is USD 464.73 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
SV Wall Street
NSE: INNOVACAP.NS

Innova Captab Limited

CEO Mr. Manoj Kumar Lohariwala
IPO Date Dec. 29, 2023
Location India
Headquarters SCO No. 301, Second Floor
Employees 1,600
Sector Healthcare
Industries
Description

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial, erectile dysfunction, anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through its network of distributors and pharmacies, as well as online through various e-commerce pharmacy sites. The company was incorporated in 2005 and is based in Panchkula, India.

StockViz Staff

February 2, 2025

Any question? Send us an email